Lessons Learned From Direct-to-Consumer Genetic Testing

Affiliations

PMID: 32008642
DOI: 10.1016/j.cll.2019.11.005

Abstract

The number of companies offering direct-to-consumer genetic tests is increasing. There is growing concern over whether direct-to-consumer genetic companies should be allowed to offer clinically relevant testing that has only been possible under medical care. Direct-to-consumer genetic testing can be incomplete, inaccurate, and inappropriate. The usefulness of such testing is extremely limited and it is unclear how well customers understand reported results. Research on the long-term impact of direct-to-consumer genetic testing is necessary to determine if stricter regulations regarding the performance of direct-to-consumer genetic testing are necessary.

Keywords: BRCA1; BRCA2; Cancer; Direct-to-consumer genetic testing.

Conflict of interest statement

Disclosure The authors have nothing to disclose.

Similar articles

Committee Opinion No. 724: Consumer Testing for Disease Risk
Committee on Genetics. Obstet Gynecol 130 (5), e270-e273. Nov 2017. PMID 29064973.
With the increased emphasis on patient-driven health care and readily available access to patients through the internet and media, many genetic testing companies have beg …
Committee Opinion No. 724 Summary: Consumer Testing for Disease Risk
Obstet Gynecol 130 (5), 1176-1177. Nov 2017. PMID 29064967.
With the increased emphasis on patient-driven health care and readily available access to patients through the internet and media, many genetic testing companies have beg …
Genetic Testing for Breast and Ovarian Cancer Susceptibility: Evaluating Direct-To-Consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 53 (27), 603-6. 2004. PMID 15254451.
Breast and ovarian cancer are the second and fifth leading causes of cancer death, respectively, among women in the United States. One in eight women will have breast can …
Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review
L Covolo et al. J Med Internet Res 17 (12), e279. 2015. PMID 26677835. - Review
The impact of DTC-GT on consumers' health perceptions and behaviors is an emerging concern. However, negative effects on consumers or health benefits have yet to be obser …
Genetic Tests for Breast and Ovarian Cancer [Internet]
LK Juvet et al. Feb 2008. PMID 29319983. - Review
Background Breast cancer is the most commonly diagnosed cancer in women. In 2005, there were about 3000 incident cases of breast cancer in Norway. Ovarian canc …